Devyser and QIAGEN collaborate on pre-analytical workflow for fetal RHD screening
Fetal derived cell-free DNA (cfDNA) is a key analyte for determining fetal RHD status in plasma...
News | April 15, 2019
Contact an expert at Devyser
If you have a question, feel free to send us a message. One of our team members will get in touch with you as soon as possible.
Approval of Devyser’s RHD product in Canada
Devyser is today announcing that its product for non-invasive fetal RHD testing has been granted...
Devyser Diagnostics AB publishes quarterly report for the period January to March 2023
“The first quarter of the year saw continued strong growth, record gross margin and the launching...
Devyser’s clinical laboratory in Atlanta receives CLIA certification
Devyser is today announcing that the company’s clinical testing laboratory in Roswell in Atlanta,...